Skip to search formSkip to main contentSkip to account menu

AM-0715

Known as: AM 0715, AM 715, AM0715 
National Institutes of Health

Papers overview

Semantic Scholar uses AI to extract papers important to this topic.
1990
1990
Norfloxacin (NFLX, AM-715), a new quinolone antibiotic agent, was evaluated clinically and bacteriologically for its efficacy and… 
1990
1990
Norfloxacin (NFLX, AM-715), a new synthetic antibacterial agent, was administered to 18 child patients with infectious diseases… 
1990
1990
We studied clinical effects of norfloxacin (NFLX, AM-715) tablets. The results we found are summarized as follows: 1. Ten… 
Highly Cited
1983
Highly Cited
1983
The mechanisms of the renal excretion of AM-715, a synthetic antimicrobial agent, were studied in rabbits, dogs, and humans. In… 
Highly Cited
1983
Highly Cited
1983
A comparison was made of the in vitro activities of norfloxacin and of nine other orally administered antibacterial agents… 
1983
1983
Norfloxacin is a new orally absorbed quinoline derivative structurally related to nalidixic acid but showing an expanded… 
1983
1983
1. Ito, A., Hirai, K., Inoue, M., Koga, H., Suzue, S., Irikura, T., Mitsuhashi, S.: In vitro antibacterial activity of AM-715, a… 
1981
1981
Authors describe structure-activity relationships in quinolone group and report a study of the antibacterial activity of two new…